Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01557270
Other study ID # GernerDex001
Secondary ID
Status Completed
Phase Phase 3
First received December 5, 2011
Last updated December 3, 2012
Start date March 2012
Est. completion date November 2012

Study information

Verified date December 2012
Source Paracelsus Medical University
Contact n/a
Is FDA regulated No
Health authority Austria: Agency for Health and Food SafetyAustria: Ethikkommission
Study type Interventional

Clinical Trial Summary

The purpose of this study is to test the efficacy and safety of dexmedetomidine added to ropivacaine in patients undergoing shoulder surgery.


Description:

Peripheral nerve blocks are used throughout the world in lieu of general anesthesia and, more commonly, to provide analgesia and opioid sparing in the postoperative course. Long acting local anesthetics, such as ropivacaine, can provide analgesia for 11.5 ± 5 hours. This leads to many patients reporting their first pain in the evening and nighttime hours when access to healthcare providers and support is most limited. A number of additives to local anesthetics have been studied in humans with limited success. Recent work by a group in Michigan found a dose dependent increase in the duration of analgesia to a thermal stimulus when dexmedetomidine was added to ropivacaine for sciatic nerve blocks in rat.

The goal of the study is to investigate the safety and efficacy of dexmedetomidine added to ropivacaine for interscalene brachial plexus nerve block for shoulder surgery in humans. Provided the initial safety can be established, the trial will continue to evaluate secondary goals including the duration of analgesia, onset of sensory and motor blockade, and opioid-induced side effects. Tertiary outcomes will include subject satisfaction.


Recruitment information / eligibility

Status Completed
Enrollment 62
Est. completion date November 2012
Est. primary completion date November 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- ASA I-III adult subjects

- Age 18-75

- Elective shoulder surgery

- Plan for interscalene brachial plexus block combined with general anesthesia

- Interscalene block

- Willingness to be contacted postoperatively for brief (5-10min) phone call questionnaires

- Written informed consent

Exclusion Criteria:

- Age < 18

- Age > 75

- Inability to understand protocol due to language barrier; difficulty with German language

- Chronic pain requiring daily opioids > 15 mg oral morphine equivalents (equals oral usage of > 10 mg oxycodone/daily; > 5 mg methadone/day; > 4 mg hydromorphone/day)

- Moderate (NRS pain score > 5) daily average pain

- Daily use of gabapentin, pregabalin, tricyclic antidepressant, serotonin- norepinephrine reuptake inhibitor, tramadol

- Hypersensitivity to amide local anesthetics

- History of hypersensitivity or allergic reaction to clonidine or dexmedetomidine

- Uncontrolled anxiety

- Schizophrenia or bipolar disorder

- Preexisting nerve damage (sensory or motor) in the extremity to be blocked

- Peripheral neuropathy

- Significant cardiovascular disease (second (Mobitz II type) or third degree heart block, congestive heart failure, chronic heart failure NYHA III-IV, symptomatic coronary artery disease CSS III-IV)

- BMI > 35

- Uncontrolled diabetes (blood sugar > 250 recorded in last 30 days or HbA1c > 7.5%)

- Chronic clonidine therapy (clonidine patch - Catapres or clonidine tablets)

- Hepatic Impairment (CHILD B or higher)

- Renal Impairment (creatinin > 2.0 mg/dl)

- Ongoing drug or alcohol abuse

- Pregnancy

- Prisoners

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
dexmedetomidine
ropivacaine 100 mg + 150 mcg dexmedetomidine, single shot perineural application
saline
ropivacaine + saline placebo, single shot perineural application

Locations

Country Name City State
Austria Paracelsus Medical University, Department of Anesthesiology, Perioperative and Intensive Care Medicine Salzburg

Sponsors (1)

Lead Sponsor Collaborator
Prof. Peter Gerner, M.D.

Country where clinical trial is conducted

Austria, 

References & Publications (3)

Brummett CM, Amodeo FS, Janda AM, Padda AK, Lydic R. Perineural dexmedetomidine provides an increased duration of analgesia to a thermal stimulus when compared with a systemic control in a rat sciatic nerve block. Reg Anesth Pain Med. 2010 Sep-Oct;35(5):427-31. doi: 10.1097/AAP.0b013e3181ef4cf0. — View Citation

Brummett CM, Hong EK, Janda AM, Amodeo FS, Lydic R. Perineural dexmedetomidine added to ropivacaine for sciatic nerve block in rats prolongs the duration of analgesia by blocking the hyperpolarization-activated cation current. Anesthesiology. 2011 Oct;115(4):836-43. doi: 10.1097/ALN.0b013e318221fcc9. — View Citation

Brummett CM, Padda AK, Amodeo FS, Welch KB, Lydic R. Perineural dexmedetomidine added to ropivacaine causes a dose-dependent increase in the duration of thermal antinociception in sciatic nerve block in rat. Anesthesiology. 2009 Nov;111(5):1111-9. doi: 10.1097/ALN.0b013e3181bbcc26. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Efficacy of dexmedetomidine in perineural application The time until the patient describes the blockade as completely gone will be analysed and compared between the groups. 24 hrs No
Primary Safety of dexmedetomidine in perineural application Any serious and/or unexpected adverse (AE) events will be assessed on an individual basis by the Principal Investigator and the DSMB. After the first twenty subjects (10 controls and 10 receiving study agent) have completed the study, the data will be reviewed. Provided the DSMB determines the initial safety is established, enrollment will proceed until a total of 62 subjects (31 subjects/group) have been accrued. 30 days Yes
Secondary Analgesia Analgesia will be assessed based on postoperative pain scores first 24-48 hrs No
Secondary Onset of sensory blockade The subject's sensory function will be measured every 2 minutes for the first 20 minutes, until the loss of sensory function in the dermal distribution of the shoulder. every 3 minutes for the first 21 minutes No
Secondary Duration of motor blockade The time to return of motor strength will be recorded in the subject's postoperative course. first 24-48 hrs No
Secondary Opioid-induced side effects Opioid-induced side effects will be recorded in the subject's postoperative course. first 24-48 hrs No
See also
  Status Clinical Trial Phase
Completed NCT05114187 - An Internet-Based Education Program for Care Partners of People Living With Dementia N/A
Completed NCT05655364 - Development of a Breastfeeding Supportive Mobile Application N/A
Completed NCT04428034 - Learning Skills Together Pilot Study N/A
Recruiting NCT05914766 - An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer N/A
Completed NCT06395857 - Visual Arts-based Intervention for Community-dwelling Stroke Survivors N/A
Not yet recruiting NCT05623202 - Pilot Study of Capacity-oriented Intervention to Promote Food Security and Diet Quality Among Hispanics/Latinos N/A
Enrolling by invitation NCT02391766 - Group Intervention Empowerment Dementia Phase 0
Completed NCT01179854 - Remegal Different Doses in Patients With Refractory Partial Seizures Phase 2
Recruiting NCT06024083 - Skills Video Intervention for Chinese/Chinese Americans N/A
Completed NCT06384612 - The Effect Of The Use Of Pocket Cards In An Undergraduate Nursıng N/A
Completed NCT04087551 - Development of the Balance Recovery Falls-Efficacy Scale for the Community-dwelling Older Adults N/A
Recruiting NCT05512624 - Integrating a Mental Health Intervention Into Primary Health Care for Refugees N/A
Completed NCT04633434 - Evaluation Study of Talk Parenting Skills N/A
Not yet recruiting NCT04493944 - Edible Seaweeds and Health: Quality Biomarkers to Support Consumer Acceptance N/A
Completed NCT04867005 - Advance Care Planning in Primary Care: a Cluster Randomized Clinical Trial N/A
Completed NCT04161820 - The Effect of Education Based on the Chronic Care Model (StrokeCARE) in Patients With Ischemic Stroke N/A
Completed NCT06082895 - The Effect of Motivational Interviewing Method on Birth Self-efficacy N/A
Completed NCT05574764 - ABC Mental Health: A Behavioral Study of K-12 Teachers and School Staff N/A
Completed NCT03758027 - CARESS: An Investigation of Effects of CARESS N/A
Completed NCT04911504 - The Effects of Resilience and Self-efficacy on Nurses' Compassion Fatigue